These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2878211)

  • 1. Efficacy of Pasteur hepatitis B vaccine in medical students.
    Hengster P; Kofler H; Eigentler A; Larcher C; Petzer A; Schulz T; Fritsch P; Dierich MP
    Lancet; 1986 Dec; 2(8519):1339-40. PubMed ID: 2878211
    [No Abstract]   [Full Text] [Related]  

  • 2. Is nonresponsiveness to hepatitis B vaccine due to latent hepatitis B virus infection?
    Luo KX; Wang LP; Nie J; Jiang S
    J Infect Dis; 1992 Apr; 165(4):777-8. PubMed ID: 1532408
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolonged immunity after late booster doses of hepatitis B vaccine.
    Jilg W; Schmidt M; Deinhardt F
    J Infect Dis; 1988 Jun; 157(6):1267-9. PubMed ID: 2967336
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of intradermal hepatitis B immunization of hospital staff.
    McKee CM; Duke P; McEvoy MB; Kelsey MC
    Int J STD AIDS; 1990 Jan; 1(1):32-4. PubMed ID: 2151564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine.
    Weber DJ; Rutala WA; Samsa GP; Santimaw JE; Lemon SM
    JAMA; 1985 Dec; 254(22):3187-9. PubMed ID: 2933532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus infection among Swedish adults: aspects on seroepidemiology, transmission, and vaccine response.
    Struve J
    Scand J Infect Dis Suppl; 1992; 82():1-57. PubMed ID: 1386474
    [No Abstract]   [Full Text] [Related]  

  • 7. [Limited value of anti-HBs determination following vaccination against hepatitis B].
    Heijtink RA
    Ned Tijdschr Geneeskd; 1987 Aug; 131(33):1443-4. PubMed ID: 2959868
    [No Abstract]   [Full Text] [Related]  

  • 8. Intradermal hepatitis B virus vaccination for low- or non-responded health-care workers.
    Yasumura S; Shimizu Y; Yasuyama T; Hiroki O; Okada K; Tsukishiro T; Tsuchida T; Higuchi K; Watanabe A
    Acta Med Okayama; 1991 Dec; 45(6):457-9. PubMed ID: 1838229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity study of a plasma-derived heat-inactivated hepatitis-B vaccine in newborn babies: a randomised dose-response study.
    Ip HM; Wong VC; Reesink HW; Lelie PN; Yeung CY; Ma HK
    Asia Oceania J Obstet Gynaecol; 1988 Sep; 14(3):367-71. PubMed ID: 2972271
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune response to hepatitis B vaccine in premature neonates.
    Chawareewong S; Jirapongsa A; Lokaphadhana K
    Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):39-40. PubMed ID: 1835140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of yeast-derived hepatitis B vaccine from two different producers.
    Dahl-Hansen E; Siebke JC; Frøland SS; Degré M
    Epidemiol Infect; 1990 Feb; 104(1):143-9. PubMed ID: 2137785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization against hepatitis B--what can we expect? Results of a survey of antibody response to immunization in persons 'at risk' of occupational exposure to hepatitis B.
    Westmoreland D; Player V; Heap DC; Hammond A
    Epidemiol Infect; 1990 Jun; 104(3):499-509. PubMed ID: 2140795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to heat-inactivated hepatitis B vaccine (CLB-3 micrograms) in hemodialysis patients and occupational risk personnel: a one year follow-up.
    Yoshida FT; Takahashi C; Mercadante LA; Camargo IF; Schatzmayr HG
    Rev Inst Med Trop Sao Paulo; 1988; 30(1):11-6. PubMed ID: 2975824
    [No Abstract]   [Full Text] [Related]  

  • 14. Should individuals with anti-HBs as the only marker of infection with hepatitis B receive hepatitis B vaccine?
    MacLeod JE; MacSween HM; Warner HA; Aterman K
    Can J Public Health; 1985; 76(4):229-32. PubMed ID: 2932209
    [No Abstract]   [Full Text] [Related]  

  • 15. Qualitative analysis of the humoral immune response to the "a" determinant of HBs antigen after inoculation with plasma-derived or recombinant vaccine.
    Waters JA; O'Rourke SM; Richardson SC; Papaevangelou G; Thomas HC
    J Med Virol; 1987 Feb; 21(2):155-60. PubMed ID: 2434612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.
    Frey S; Dagan R; Ashur Y; Chen XQ; Ibarra J; Kollaritsch H; Mazur MH; Poland GA; Reisinger K; Walter E; Van Damme P; Braconier JH; Uhnoo I; Wahl M; Blatter MM; Clements D; Greenberg D; Jacobson RM; Norrby SR; Rowe M; Shouval D; Simmons SS; van Hattum J; Wennerholm S; Gress JO
    J Infect Dis; 1999 Dec; 180(6):2018-22. PubMed ID: 10558961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to hepatitis B vaccine in subjects positive for serum hepatitis B core antibody alone.
    Wu JS; Tam KM
    Taiwan Yi Xue Hui Za Zhi; 1988 Oct; 87(10):944-7. PubMed ID: 3241153
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of an anti-hepatitis-B vaccination in a population at risk].
    Stellato M; Carbi S; Tosolini S
    Boll Ist Sieroter Milan; 1989; 68(1):34-41. PubMed ID: 2535244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between peripheral lymphocyte subsets and antibody to hepatitis B surface antigen response in hepatitis B vaccine recipients.
    Lee SD; Tong MJ
    Scand J Infect Dis; 1985; 17(3):333-5. PubMed ID: 3933107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of hepatitis B vaccine in patients infected with Schistosoma mansoni.
    Bassily S; Hyams KC; el-Ghorab NM; Mansour MM; el-Masry NA; Dunn MA
    Am J Trop Med Hyg; 1987 May; 36(3):549-53. PubMed ID: 2953263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.